Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS.
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder characterized by severe gastrointestinal dysmotility, cachexia, ptosis, ophthalmoparesis, peripheral neuropathy and leukoencephalopathy. The disease is due to a thymidine phosphorylase defect. This enzyme catalyses the phosphorolysis of thymidine to thymine and deoxyribose 1-phosphate. For this reason, increased levels of thymidine in plasma and urine are found in MNGIE patients. Haemodialysis can reduce circulating plasma thymidine levels and can be beneficial in some MNGIE patients. We developed a fast analytical method based on HPLC-ESI-MS/MS capable of identifying pyrimidine nucleotides (thymine, cytosine, uracil) and nucleosides (thymidine, citidine, uridine) in plasma and urine after direct dilution of the samples without pre-treatment. In the patient studied, we observed a significant reduction of plasmatic and urinary thymidine levels during and after dialysis. However, we noted a progressive reduction of the initial thymidine level after some dialytic trials. This method will be useful not only for thymidine level follow-up during dialysis in MNGIE patients but also for the improvement of the diagnosis or diagnostic suspect in other pyrimidine defects such as dihydropyrimidine dehydrogenase deficiency, dihydropyrimidinase deficiency and ureidopropionase deficiency.
Metabolic and Neuromuscular Unit, A. Meyer Children's Hospital, Department of Paediatrics, University of Florence, Florence, Italy. g.lamarca@meyer.it
G
G
la Marca
S
S
Malvagia
B
B
Casetta
E
E
Pasquini
I
I
Pela
M
M
Hirano
M A
MA
Donati
E
E
Zammarchi
D000328:Adult; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D017237:Mitochondrial Encephalomyopathies / Q000097:blood* / Q000628:therapy / Q000652:urine*; D006435:Renal Dialysis; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D013936:Thymidine / Q000032:analysis / Q000097:blood / Q000652:urine; D013939:Thymidine Phosphorylase / Q000172:deficiency
D013939:Thymidine Phosphorylase; D013936:Thymidine